<DOC>
	<DOCNO>NCT00898144</DOCNO>
	<brief_summary>RATIONALE : Studying Pap smear laboratory woman atypical glandular cell unspecified significance may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This research study look Pap smear woman enrol clinical trial GOG-171 .</brief_summary>
	<brief_title>Study Pap Smears From Patients Enrolled Clinical Trial GOG-171</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine diagnostic accuracy use previously report morphometric criterion chromatin distribution , short distance nucleus , and/or ratio nucleoli area nucleus area conventional Pap smear patient cytologic diagnosis atypical glandular cell unspecified significance ( AGUS ) predict presence significant glandular lesion ( i.e. , adenocarcinoma situ [ AIS ] invasive cancer ) and/or squamous lesion ( i.e. , cervical intraepithelial neoplasia [ CIN2 CIN3 ] ) cervix . Secondary - To optimize diagnostic accuracy use chromatin distribution , short distance nucleus , and/or ratio nucleoli area nucleus area conventional Pap smear patient cytologic diagnosis AGUS predict presence significant glandular lesion ( i.e. , AIS invasive cancer ) and/or squamous lesion ( i.e. , CIN2 CIN3 ) cervix . OUTLINE : Previously collect slide Pap smear patient enrol clinical trial GOG-171 assess nuclear chromatin distribution , short distance central point neighbor cell nuclei , nucleoli area/nucleus area ( N/N ) ratio via morphometric analysis .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cytologically confirm atypical glandular cell unspecified significance Original Pap smear use define diagnosis must available review Previously enrol GOGJAPAN onto clinical trialGOG171 Must eligible evaluable primary objective GOG171 Gave permission use specimens future cancer research GOG171 Underwent loop electrosurgical excision procedure/large loop excision transformation zone ( LEEP/LLETZ ) procedure clinical trial GOG171 determine presence cervical intraepithelial neoplasia ( CIN2 CIN3 ) , significant glandular lesion ( AIS ) , invasive cancer PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>cervical intraepithelial neoplasia grade 2</keyword>
	<keyword>cervical intraepithelial neoplasia grade 3</keyword>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>atypical squamous cell undetermined significance</keyword>
</DOC>